Simulations Plus, Inc. cotiza a 18.50 USD y tiene una capitalización bursátil de $374M. En los últimos 12 meses ha facturado $82M con un margen de flujo de caja libre del 22.0%. Cotiza a 15.2 veces su flujo de caja libre (P/FCF) y a un PER de 46.1. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-01 |
|---|---|---|---|---|
| Real | — | $0.30 | $0.35 | $0.13 |
| Estimado | $0.16 | $0.23 | $0.31 | $0.20 |
| Sorpresa | — | +30.4% | +12.9% | -35.0% |
| Métrica | SLP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 58.4% | 57.0% | +1.3% |
| Operating Margin | -89.3% | -38.6% | -50.7% |
| Net Margin | -81.7% | -33.6% | -48.2% |
| FCF Margin | 22.0% | -13.9% | +35.8% |
| ROE | -51.9% | -40.4% | -11.5% |
| ROA | -49.0% | -32.0% | -17.0% |
| Current Ratio | 7.67 | 2.84 | +4.83 |
| Debt / Equity | — | 0.28 | — |